Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer

Julie R. Brahmer; Drew M. Pardoll

doi:10.1158/2326-6066.CIR-13-0078

AACR Publications

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Search for this keyword

Advanced Search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News

Cancer Immunology at the Crossroads: Thoracic Oncology

Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer

Julie R. Brahmer and Drew M. Pardoll

Julie R. Brahmer

Authors' Affiliation: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Drew M. Pardoll

Authors' Affiliation: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/2326-6066.CIR-13-0078 Published August 2013

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: July 2013 to December 2019

	Abstract	Full-text HTML	PDF
Total	9903	18543	6418

Cited By

Article Information

Volume 1, Issue 2, pp. 85-91

DOI

https://doi.org/10.1158/2326-6066.CIR-13-0078

PubMed

24777499

Published By

American Association for Cancer Research

Print ISSN

2326-6066

Online ISSN

2326-6074

History

Received June 20, 2013
Accepted June 20, 2013
Published first July 22, 2013.

Article Versions

Previous version (July 22, 2013 - 07:19).
You are viewing the most recent version of this article.

Author Information

Julie R. Brahmer and
Drew M. Pardoll

Authors' Affiliation: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Corresponding Author:
Drew M. Pardoll, The Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Room G-94, Baltimore, MD 21287-0013. Phone: 410-502-7159; Fax: 410-614-9334

View Full Text

PreviousNext

August 2013
Volume 1, Issue 2

Table of Contents
Table of Contents (PDF)
About the Cover

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer

Message Subject (Your Name) has forwarded a page to you from Cancer Immunology Research

Message Body (Your Name) thought you would be interested in this article in Cancer Immunology Research.

Your Personal Message

Citation Tools

Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer

Julie R. Brahmer and Drew M. Pardoll

Cancer Immunol Res August 1 2013 (1) (2) 85-91; DOI: 10.1158/2326-6066.CIR-13-0078